Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Trehalose + hyaluronic acid + carbomer** is a preservative-free, high-viscosity topical ophthalmic artificial-tear formulation marketed as **Thealoz Duo Gel** and **Thealoz Gel** by Laboratoires Théa. It combines trehalose, an osmoprotective disaccharide that helps protect ocular-surface cells from desiccation and oxidative stress; sodium hyaluronate, a lubricating and water-retaining polymer; and carbomer, a mucoadhesive viscosity-enhancing polymer that prolongs ocular-surface residence. The gel is used for dry eye disease and ocular-surface discomfort, including tear-film instability and postoperative ocular irritation after cataract phacoemulsification. Clinical studies reported improvements in tear break-up time, ocular-surface staining, symptoms, and treatment satisfaction, with lower daily instillation frequency than less-viscous trehalose/hyaluronate drops.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on trehalose + hyaluronic acid + carbomer.